ResMed Doubles Down On Connected Care With $800m Brightree Acquisition
Resmed continues its push to integrate healthcare analytics and cloud-based software into its respiratory management devices with its proposed $800m acquisition of Brightree, a developer of cloud-based software for improving clinical and business performance for providers of post-acute care. The move expands ResMed's offerings to its core HME/DME sleep customers and opens doors in new market segments, including home health and hospital channels, where there is a high prevalence of sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.
You may also be interested in...
Propeller Health bills itself as a digital respiratory therapeutics company, providing a mobile platform that communicates with sensors on patients' inhaler devices to help them manage chronic obstructive pulmonary disease and asthma. This the second major acquisition ResMed has announced in the last month.
ResMed, one of the dominant players in the sleep-disorder market, has signed a definitive deal to buy Minnesota-based MatrixCare to augment its expanding software-as-a-service business with MatrixCare's electronic health record platform for long-term care settings.
Devices that collect and communicate patient data present opportunities for device-makers to have a closer relationship with end-users, but most device companies have little experience working directly with patients. Device firms need to close this gap by seeing the patients who use their devices as their primary customers, rather than just focusing on intermediaries like doctors, hospitals, and payers, industry experts tell Medtech Insight.